Our strategy
OUR STRATEGY STARTS WHERE PATIENTS ARE LEFT BEHIND
In the gap between global medical innovation and local healthcare realities.
INNOVATIVE BIOSIMILARS FOR RARE DISEASES, HEALTH AND SUSTAINABLE IMPACT
At NEXTGEN THERAPEUTICS, our strategy is driven by a strong and unwavering belief: every patient across the MENA region deserves fair and equitable access to high-quality biological treatments, including for the rarest conditions.
Our commitment to biosimilars in rare diseases reflects a clear ambition: to reduce therapeutic disparities, support medical excellence across the region, and contribute to more resilient and sustainable healthcare systems.
Strengthening Healthcare Through Innovation and Commitment
Bringing innovation where it is most needed
We believe progress in healthcare comes from a clear vision and decisive action. By prioritizing innovation, technology transfer, and patient access, we are laying the foundations for a stronger, more independent pharmaceutical industry in the MENA region.
Investing in technology transfer
We are fully engaged in transferring know-how, enabling local manufacturing, and building industrial capabilities to lay the foundations for national pharmaceutical independence.
Creating a positive impact on public health and the national economy
By offering reliable, accessible, and cost-effective therapeutic alternatives, we help ease the financial burden on the healthcare system while ensuring optimal patient care.
Being a trusted partner to the MENA healthcare system
We aspire to become a key player in the MENA health ecosystem, working hand in hand with authorities, healthcare professionals, and researchers to build an ethical, forward-thinking, and resilient medical future.
Our vision
NEXTGEN THEARPEUTICS stands for a pharmaceutical industry across the MENA region driven by innovation, scientific excellence, and healthcare resilience.
As a human-scale company with a with a regional ambition, NEXTGEN THERAPEUTICS is committed to improving patient outcomes, supporting sustainable healthcare systems, and contributing to the long-term development and transformation of the region’s life sciences industry.
